Quote | Nurix Therapeutics Inc. (NASDAQ:NRIX)
Last: | $14.13 |
---|---|
Change Percent: | -0.07% |
Open: | $13.59 |
Close: | $14.13 |
High: | $14.44 |
Low: | $13.59 |
Volume: | 687,984 |
Last Trade Date Time: | 04/23/2024 03:00:00 am |
News | Nurix Therapeutics Inc. (NASDAQ:NRIX)
SAN FRANCISCO, May 09, 2023 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein modulation drugs designed to treat patients with hematologic malignancies and solid tumors, today announced that Arthur T. Sands, M.D., P...
Oral presentation features structural disclosure and preclinical characterization of NX-2127, Nurix’s lead BTK degrader for the treatment of B-cell malignancies Poster presentation highlights specificity and potency of NX-5948 and superior cellular activity of both NX-2127 and ...
Message Board Posts | Nurix Therapeutics Inc. (NASDAQ:NRIX)
Subject | By | Source | When |
---|---|---|---|
https://ih.advfn.com/stock-market/NASDAQ/nurix-therapeutics-NRIX/stock-news/8889 | TheFinalCD | investorshub | 08/23/2022 11:04:42 PM |
what the F is wrong with this fkn | infamous | investorshub | 03/24/2021 7:21:29 PM |
$CEO: Dr. Arthur T. Sands | Phosphene | investorshub | 12/09/2020 11:20:59 PM |
Strategic partnerships with Sanofi and Gilead Sciences Inc. | Phosphene | investorshub | 12/08/2020 5:01:07 AM |
Data support a planned clinical trial of NX-2127 | Phosphene | investorshub | 12/08/2020 4:50:47 AM |
News, Short Squeeze, Breakout and More Instantly...
Nurix Therapeutics Inc. Company Name:
NRIX Stock Symbol:
NASDAQ Market:
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings. Net revenue (managed) ...
U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday. Shares of Applied Digital Corporation (NASDAQ: ...
Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $...